FDA
-
-
-
-
-
-
-
Autolus presents CARLYSLE trial data for lupus treatment at ASH meeting
-
-
-
-
-
-
-
Autolus Therapeutics Presents Clinical Data Updates at the American College of Rheumatology Convergence 2025
-
-
-
-
-
-
-
GPCR-Targeting Therapies Market Poised for Strong Growth During the Forecast Period (2025-2034) Across 7MM Due to the Rising Cancer Diagnoses and Drug Pipeline Expansion | DelveInsight
-
-
-
-
-
-
-
Autolus Therapeutics Presents Clinical Data Updates at the 2025 European Hematology Association (EHA) Congress
-
-
-
-
-
-
-
Innate Pharma Proposes to Its Shareholders to Transform Its Corporate Governance Structure Into a Board of Directors and to Change Its Composition
-
-
-
-
-
-
-
Autolus Therapeutics to Report Fourth Quarter 2024 Financial Results and Host Conference Call on March 20, 2025
-
-
-
-
-
-
-
Autolus Therapeutics (AUTL) Announces Publication of Data from the FELIX study of obe-cel in r/r Adult B-ALL Patients in The New England Journal of Medicine
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

